C030048H21Rik Inhibitors
C130039O16Rik, a gene product of the RIKEN cDNA C130039O16, is a protein that intricately participates in fundamental cellular processes. While specific details about its function are currently limited, a comprehensive examination of available data suggests its involvement in pivotal cellular pathways and potential roles in gene expression regulation. C130039O16Rik is positioned at the nexus of multiple signaling cascades, including but not limited to MAPK/ERK, PI3K-AKT, JNK, and TGF-β pathways, highlighting its complexity and the need for nuanced exploration. In understanding the functional intricacies of C130039O16Rik, it is imperative to delve into its possible roles within these pathways. Preliminary data indicates that C130039O16Rik might act as a modulator or mediator in these cascades, participating in signal transduction events that govern cellular responses. Its involvement in pathways such as MAPK/ERK suggests a potential impact on cellular proliferation and differentiation, while interactions with PI3K-AKT pathways hint at regulatory roles in cell survival and growth. The intricate network of signaling pathways associated with C130039O16Rik emphasizes its significance in coordinating cellular events, positioning it as a subject of substantial interest for further investigation.
Turning attention to inhibition, the exploration of C130039O16Rik inhibitors unveils a realm of research possibilities. Understanding the regulatory mechanisms of C130039O16Rik through inhibition can shed light on its functional significance within cellular pathways. General inhibitors targeting MAPK/ERK, PI3K-AKT, or JNK pathways could indirectly impact C130039O16Rik, providing insights into its potential roles as a signaling mediator or modulator. The challenge lies in deciphering the specific interactions and cross-talk that occur between C130039O16Rik and these pathways, offering a nuanced perspective on its regulatory influence within the intricate cellular landscape. Research endeavors in this direction can contribute to unraveling the complexities of cellular signaling and gene expression regulation orchestrated by C130039O16Rik, marking a significant step toward a more comprehensive understanding of this enigmatic gene product.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
VX 745 | 209410-46-8 | sc-361401 sc-361401A | 10 mg 50 mg | $183.00 $842.00 | 4 | |
VX-745, a JAK inhibitor, may indirectly influence C030048H21Rik by suppressing the JAK-STAT pathway. Its inhibitory action on JAK could disrupt downstream signaling, potentially influencing cellular processes linked to this protein through modulation of cytokine-mediated responses. | ||||||
LY 303511 | 154447-38-8 | sc-202215 sc-202215A | 1 mg 5 mg | $67.00 $278.00 | 3 | |
LY303511, an inhibitor of PI3K, may disrupt the PI3K-AKT pathway, potentially influencing cellular processes linked to C030048H21Rik. Its impact on the regulatory mechanisms of this enigmatic protein could lead to alterations in gene expression dynamics. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125, a JNK inhibitor, may indirectly influence C030048H21Rik by suppressing c-Jun N-terminal kinase activity, impacting gene expression dynamics associated with this enigmatic protein through modulation of cellular stress responses. | ||||||
AZD5363 | 1143532-39-1 | sc-503190 | 5 mg | $309.00 | ||
AZD5363, an AKT inhibitor, disrupts the PI3K-AKT pathway, potentially influencing cellular processes linked to C030048H21Rik. Its impact on the regulatory mechanisms of this enigmatic protein could lead to alterations in gene expression dynamics. | ||||||
SB 590885 | 405554-55-4 | sc-363287 sc-363287A | 10 mg 50 mg | $223.00 $942.00 | ||
SB590885, a selective GSK-3 inhibitor, may influence C030048H21Rik by disrupting GSK-3 signaling, impacting downstream cellular responses and potentially altering gene expression dynamics associated with this enigmatic protein. | ||||||
SIS3 hydrochloride | 521984-48-5 | sc-253565 | 5 mg | $334.00 | 2 | |
SIS3, a selective inhibitor of the TGF-β type I receptor, may indirectly impact C030048H21Rik by modulating the TGF-β pathway. Its inhibitory action on the TGF-β receptor could disrupt downstream signaling, potentially influencing cellular processes linked to this protein. | ||||||
MK-2206 dihydrochloride | 1032350-13-2 | sc-364537 sc-364537A | 5 mg 10 mg | $182.00 $332.00 | 67 | |
MK-2206, an AKT inhibitor, disrupts the PI3K-AKT pathway, potentially influencing cellular processes linked to C030048H21Rik. Its impact on the regulatory mechanisms of this enigmatic protein could lead to alterations in gene expression dynamics. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580, a p38 MAP kinase inhibitor, may indirectly influence C030048H21Rik by altering the dynamics of cellular responses crucial for this enigmatic protein through modulation of the MAPK pathway, particularly p38 MAP kinase. | ||||||
BI 78D3 | 883065-90-5 | sc-203840 sc-203840A | 10 mg 50 mg | $204.00 $810.00 | 2 | |
BI-78D3, a JNK inhibitor, may indirectly influence C030048H21Rik by suppressing c-Jun N-terminal kinase activity, impacting gene expression dynamics associated with this enigmatic protein through modulation of cellular stress responses. | ||||||
GSK 2334470 | 1227911-45-6 | sc-364501 sc-364501A | 10 mg 50 mg | $199.00 $1165.00 | 1 | |
GSK2334470, an AKT inhibitor, disrupts the PI3K-AKT pathway, potentially influencing cellular processes linked to C030048H21Rik. Its impact on the regulatory mechanisms of this enigmatic protein could lead to alterations in gene expression dynamics. | ||||||